Quest for a Cure

Join us for our 8th Annual Quest for a Cure Benefit!

The Castleman Disease Collaborative Network (CDCN) invites you to the 8th annual Quest for a Cure Benefit! This year’s benefit will join together patients, loved ones, and community members to raise awareness and funds for life-saving Castleman disease research. We have an exciting program planned for the evening that includes remarks from the CDCN’s co-founder, Dr. David Fajgenbaum, physician-scientist at the University of Pennsylvania, and the author of Chasing My Cure: A Doctor’s Race to Turn Hope Into Action.

Details:

  • Date: Saturday, November 12th, 2022
  • Location: Arts Ballroom, Philadelphia, PA
  • Silent Auction
  • MORE INFO COMING SOON!

*Interested in helping with this years event and joining our committee? Reach out to mileva@castlemannetwork.org

 

Sponsorships

Please support our life-saving immunology research to discover cures for Castleman disease, COVID-19, and related diseases by donating here.

Royal Court Sponsor $50,000

  • Recognition on website and materials publicizing the event
  • Name listed for one year on Cdcn.org/quest

Crusader Sponsor $25,000

  • Recognition on website and materials publicizing the event
  • Name listed for one year on Cdcn.org/quest

Castleman Sponsor $10,000

  • Recognition on website and materials publicizing the event
  • Name listed for one year on Cdcn.org/quest

King Sponsor $5,000

  • Recognition on website and materials publicizing the event
  • Name listed for one year on Cdcn.org/quest

Knight Sponsor $2,500

  • Recognition on website and materials publicizing the event

Bishop Sponsor $1,250

  • Recognition on website and materials publicizing the event

Noble Sponsor $500

  • Recognition on website and materials publicizing the event

 

 

 

 

 

About the CDCN

The CDCN’s innovative approach to transforming Castleman disease research over the last eight years has resulted in the first diagnostic criteria for Castleman disease, first treatment guidelines, first new drug target in 25 years, and the first clinical trial for patients with treatment-refractory Castleman disease. This work has been profiled on Good Morning America, New York Times, CNN, Philadelphia InquirerNPR Fresh Air, and the Lifetime TV NetworkThe CDCN has also partnered with the Chan Zuckerberg Initiative to expand the CDCN’s approach to research to advance cures for other rare diseases. 

More Information

  • Prefer to send a check by mail? Make out to “CDCN” (Castleman Disease Collaborative Network), notate ‘Quest for A Cure,’ and send to Castleman Disease Collaborative Network, PO Box 3614 Paso Robles, CA 93447
  • Questions? Email quest@castlemannetwork.org or call (610) 304-0696
  • CDCN is a 501 (c) (3) nonprofit organization. All donations are tax-deductible in accordance with IRS regulations.

 

 

Arrow Shape Facebook Instagram Twitter Youtube Play Arrow Left